The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
873293358 8732933 58 F 20100803 20160726 20120820 20160728 EXP CA-ROCHE-1101039 ROCHE 66.32 YR F Y 90.00000 KG 20160728 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
873293358 8732933 1 PS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20141,B20192,B20212,B20262, 125276 725.6 MG SOLUTION FOR INFUSION
873293358 8732933 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20141,B20192,B20212,B20262, 125276 800 MG SOLUTION FOR INFUSION
873293358 8732933 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20141,B20192,B20212,B20262, 125276 SOLUTION FOR INFUSION
873293358 8732933 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20141,B20192,B20212,B20262, 125276 728 MG SOLUTION FOR INFUSION
873293358 8732933 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20141,B20192,B20212,B20262, 125276 SOLUTION FOR INFUSION
873293358 8732933 6 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20071,B20141,B20192,B20212,B20262, 125276 SOLUTION FOR INFUSION
873293358 8732933 7 SS LIPITOR ATORVASTATIN CALCIUM 1 Unknown 0
873293358 8732933 8 SS COVERSYL PERINDOPRIL 1 Unknown 0
873293358 8732933 9 SS APO-NADOL NADOLOL 1 Unknown 0
873293358 8732933 10 SS APO-NADOL NADOLOL 1 Unknown 0
873293358 8732933 11 SS ELIQUIS APIXABAN 1 Oral 0 5 MG BID
873293358 8732933 12 C FUROSEMIDE. FUROSEMIDE 1 0
873293358 8732933 13 C SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown 0
873293358 8732933 14 C SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown DOSE INCREASED ABOUT 2 MONTHS AGO 0
873293358 8732933 15 C TYLENOL ACETAMINOPHEN 1 0
873293358 8732933 16 C EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 0
873293358 8732933 17 C XANAX ALPRAZOLAM 1 0
873293358 8732933 18 C DELATESTRYL TESTOSTERONE ENANTHATE 1 0
873293358 8732933 19 C DELESTROGEN ESTRADIOL VALERATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
873293358 8732933 1 Rheumatoid arthritis
873293358 8732933 7 Product used for unknown indication
873293358 8732933 8 Product used for unknown indication
873293358 8732933 9 Product used for unknown indication
873293358 8732933 11 Anticoagulant therapy

Outcome of event

Event ID CASEID OUTC COD
873293358 8732933 HO
873293358 8732933 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
873293358 8732933 Abasia
873293358 8732933 Abdominal pain
873293358 8732933 Aphthous ulcer
873293358 8732933 Arthralgia
873293358 8732933 Asthenia
873293358 8732933 Atrial fibrillation
873293358 8732933 Bacterial infection
873293358 8732933 Blood pressure fluctuation
873293358 8732933 Blood pressure increased
873293358 8732933 Bronchitis
873293358 8732933 Bursitis
873293358 8732933 Cardiac failure congestive
873293358 8732933 Chest pain
873293358 8732933 Contusion
873293358 8732933 Cough
873293358 8732933 Deep vein thrombosis
873293358 8732933 Diarrhoea
873293358 8732933 Dysphonia
873293358 8732933 Dyspnoea
873293358 8732933 Ear congestion
873293358 8732933 Epistaxis
873293358 8732933 Fatigue
873293358 8732933 Fungal infection
873293358 8732933 Headache
873293358 8732933 Heart rate decreased
873293358 8732933 Herpes zoster
873293358 8732933 Inflammation
873293358 8732933 Infusion related reaction
873293358 8732933 Ligament sprain
873293358 8732933 Migraine
873293358 8732933 Musculoskeletal chest pain
873293358 8732933 Musculoskeletal pain
873293358 8732933 Myalgia
873293358 8732933 Nasal congestion
873293358 8732933 Nasopharyngitis
873293358 8732933 Oral herpes
873293358 8732933 Pain
873293358 8732933 Pain in extremity
873293358 8732933 Peripheral swelling
873293358 8732933 Rash
873293358 8732933 Rectal haemorrhage
873293358 8732933 Sciatica
873293358 8732933 Sinusitis
873293358 8732933 Stress
873293358 8732933 Swelling
873293358 8732933 Thyroid disorder
873293358 8732933 Urinary tract infection
873293358 8732933 Urticaria
873293358 8732933 Weight decreased
873293358 8732933 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
873293358 8732933 1 20100621 0
873293358 8732933 2 20110510 0
873293358 8732933 3 20120802 0
873293358 8732933 4 20131108 0
873293358 8732933 5 20150420 0
873293358 8732933 6 20150813 0
873293358 8732933 7 201306 0
873293358 8732933 8 2013 20130517 0
873293358 8732933 9 2013 20130517 0
873293358 8732933 10 201309 0
873293358 8732933 11 201401 0